FDA Submits Proposed Collection of Information for Orphan Medicinal Product Designation

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for emergency processing under the Paperwork Reduction Act of 1995, related to the joint adoption of a form for orphan medicinal product designation with the European Medicines Evaluation Agency (EMEA).